Biotech · Private company
SHINKEI Therapeutics, Inc
Track this companyFree. Adds SHINKEI Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Amantadine HydrochloridePhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 1, 2024ClinicalTrials.gov NCT06253923 · fetched Nov 12, 2026